The Valley Desk

NCT06055439 · Interventional trial

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Colorectal Cancer, Gastric Cancer, Neuroendocrine Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov